Join the club for FREE to access the whole archive and other member benefits.

L-Nutra secures $47M investment to develop an innovative diet plan

Company's fasting mimicking technology could revolutionise ageing


Key points from article :

Longevity nutrition company L-Nutra raises $47m in Series D fundraising.

L-Nutra develops fasting mimicking technology that nourishes the body while keeping cells in a fasting mode, providing health benefits and enhancing cellular rejuvenation.

L-Nutra has conducted over 30 clinical trials and secured 200 worldwide patents, demonstrating the scientific rigor and efficacy of its technology.

Company's two pipelines, L-Nutra's ProLon and L-Nutra Health, focus on enhancing healthy aging and treating age-related diseases through nutrition as medicine.

L-Nutra CEO Dr Joseph Antoun says the investment reinforces trust in the company's science and mission to increase longevity and healthspan globally.

Mentioned in this article:

Click on resource name for more details.

Joseph Antoun

Chairman and CEO at L-Nutra Inc.


Company that develops and produces fasting-mimicking diet products.

Topics mentioned on this page:
Investments, Intermittent Fasting (IF)
L-Nutra secures $47M investment to develop an innovative diet plan